Literature DB >> 15870673

Phenotypic and genetic characterization of patients with features of "nonclassic" forms of cystic fibrosis.

Joshua D Groman1, Barbara Karczeski, Molly Sheridan, Terry E Robinson, M Daniele Fallin, Garry R Cutting.   

Abstract

OBJECTIVE: To determine which features of incomplete or "nonclassic" forms of cystic fibrosis (CF) are associated with deleterious CF transmembrane conductance regulator gene ( CFTR ) mutations, and to explore other etiologies for features not associated with deleterious CFTR mutations. STUDY
DESIGN: Clinical features were compared between 57 patients with deleterious mutations in each CFTR and 63 with no deleterious mutations. The Shwachman Bodian Diamond syndrome gene ( SBDS ) was sequenced to search for mutations in patients with no deleterious CFTR mutations and steatorrhea to determine if any had unrecognized Shwachman-Diamond syndrome (SDS).
RESULTS: The presence of a common CF-causing mutation, absence of the vas deferens, and Pseudomona aeruginosa in the sputum correlated with the presence of two deleterious CFTR mutations, whereas sweat chloride concentration, diagnostic criteria for CF, and steatorrhea did not. However, sweat chloride concentration correlated with CFTR mutation status in patients infected with P aeruginosa. One patient had disease-causing mutations in each SBDS .
CONCLUSIONS: Presence of a common CF-causing mutation, absence of the vas deferens and/or P aeruginosa infection in a patient with features of nonclassic CF are predictive of deleterious mutations in each CFTR , whereas steatorrhea in the same context is likely to have etiologies other than CF transmembrane conductance regulator (CFTR) dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870673      PMCID: PMC3380804          DOI: 10.1016/j.jpeds.2004.12.020

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  What is cystic fibrosis?

Authors:  Michael R Knowles; Peter R Durie
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  Nonclassic cystic fibrosis: a clinical conundrum.

Authors:  Beryl J Rosenstein
Journal:  Pediatr Pulmonol       Date:  2003-07

Review 3.  Atypical cystic fibrosis--diagnostic and management dilemmas.

Authors:  Colin Wallis
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

4.  Mutations in SBDS are associated with Shwachman-Diamond syndrome.

Authors:  Graeme R B Boocock; Jodi A Morrison; Maja Popovic; Nicole Richards; Lynda Ellis; Peter R Durie; Johanna M Rommens
Journal:  Nat Genet       Date:  2002-12-23       Impact factor: 38.330

5.  The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

Authors:  E Kerem; M Corey; B S Kerem; J Rommens; D Markiewicz; H Levison; L C Tsui; P Durie
Journal:  N Engl J Med       Date:  1990-11-29       Impact factor: 91.245

Review 6.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

7.  Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements.

Authors:  D C Wilson; L Ellis; J Zielenski; M Corey; W F Ip; L C Tsui; E Tullis; M R Knowles; P R Durie
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

8.  Nasal potential difference in cystic fibrosis patients presenting borderline sweat test.

Authors:  A Delmarco; U Pradal; G Cabrini; A Bonizzato; G Mastella
Journal:  Eur Respir J       Date:  1997-05       Impact factor: 16.671

9.  Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar.

Authors:  H Ginzberg; J Shin; L Ellis; J Morrison; W Ip; Y Dror; M Freedman; L A Heitlinger; M A Belt; M Corey; J M Rommens; P R Durie
Journal:  J Pediatr       Date:  1999-07       Impact factor: 4.406

Review 10.  Nonclassic cystic fibrosis and CFTR-related diseases.

Authors:  Michael P Boyle
Journal:  Curr Opin Pulm Med       Date:  2003-11       Impact factor: 3.155

View more
  11 in total

1.  CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.

Authors:  Molly B Sheridan; Timothy W Hefferon; Nulang Wang; Christian Merlo; Carlos Milla; Drucy Borowitz; Eric D Green; Peter J Mogayzel; Garry R Cutting
Journal:  J Med Genet       Date:  2010-11-20       Impact factor: 6.318

2.  Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors.

Authors:  Elinor Langfelder-Schwind; Barbara Karczeski; Michelle N Strecker; Joy Redman; Elaine A Sugarman; Christina Zaleski; Trisha Brown; Steven Keiles; Amy Powers; Sumheda Ghate; Rebecca Darrah
Journal:  J Genet Couns       Date:  2013-09-07       Impact factor: 2.537

3.  Loss of carbonic anhydrase XII function in individuals with elevated sweat chloride concentration and pulmonary airway disease.

Authors:  Melissa Lee; Briana Vecchio-Pagán; Neeraj Sharma; Abdul Waheed; Xiaopeng Li; Karen S Raraigh; Sarah Robbins; Sangwoo T Han; Arianna L Franca; Matthew J Pellicore; Taylor A Evans; Kristin M Arcara; Hien Nguyen; Shan Luan; Deborah Belchis; Jozef Hertecant; Joseph Zabner; William S Sly; Garry R Cutting
Journal:  Hum Mol Genet       Date:  2016-02-23       Impact factor: 6.150

4.  Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.

Authors:  Jerry A Nick; Cathy S Chacon; Sara J Brayshaw; Marion C Jones; Christine M Barboa; Connie G St Clair; Robert L Young; David P Nichols; Jennifer S Janssen; Gwen A Huitt; Michael D Iseman; Charles L Daley; Jennifer L Taylor-Cousar; Frank J Accurso; Milene T Saavedra; Marci K Sontag
Journal:  Am J Respir Crit Care Med       Date:  2010-05-06       Impact factor: 21.405

Review 5.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

6.  Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length.

Authors:  Danieli Barino Salinas; Colleen Azen; Suzanne Young; Thomas G Keens; Martin Kharrazi; Richard B Parad
Journal:  Genet Test Mol Biomarkers       Date:  2016-07-22

Review 7.  Atypical cystic fibrosis and CFTR-related diseases.

Authors:  Shruti M Paranjape; Pamela L Zeitlin
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

8.  Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

Authors:  Philip M Farrell; Beryl J Rosenstein; Terry B White; Frank J Accurso; Carlo Castellani; Garry R Cutting; Peter R Durie; Vicky A Legrys; John Massie; Richard B Parad; Michael J Rock; Preston W Campbell
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

9.  Refining the continuum of CFTR-associated disorders in the era of newborn screening.

Authors:  H Levy; M Nugent; K Schneck; D Stachiw-Hietpas; A Laxova; O Lakser; M Rock; M K Dahmer; J Biller; S Z Nasr; M Baker; S A McColley; P Simpson; P M Farrell
Journal:  Clin Genet       Date:  2016-01-20       Impact factor: 4.438

10.  CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Joshua L Deignan; Caroline Astbury; Garry R Cutting; Daniela Del Gaudio; Anthony R Gregg; Wayne W Grody; Kristin G Monaghan; Sue Richards
Journal:  Genet Med       Date:  2020-05-14       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.